Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago

Did you know that immunotherapy has shown promise in the perioperative setting for gastric and gastroesophageal junction (GEJ) adenocarcinoma?

Credit available for this activity expires: 7/11/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/transforming-gastric-and-gej-cancer-care-perioperative-2025a1000i7e?ecd=bdc_podcast_libsyn_mscpedu